Article citationsMore>>
R. J. Motzer, D. Nosov, T. Eisen, I. N. Bondarenko, V. Lesovoy, O. N. Lipatov, P. Tomczak, A. A. Lyulko, A. Alyasova, M. Harza, M. Kogan, B. Y. Alexeev, C. N. Sternberg, C. Szczylik, J. Zhang, A. L. Strahs, B. Esteves, W. J. Slichenmyer, A. Berkenblit and T. E. Hutson, “Tivozanib versus Sorafenib as Initial Targeted Therapy for Patients with Advanced Renal Cell Carcinoma: Results from a Phase III Randomized, Open-Label, Multicenter Trial,” Journal of Clinical Oncology, Vol. 30, 2012, Abstract No. 4501.
has been cited by the following article:
Related Articles:
-
D. Subba Reddy, M. Bhaskar Reddy, N. Nanda Kumar Reddy, V. Rajagopal Reddy
-
Minzhi Wei, Yujian Gan, Shengqiang Tang
-
Axel Costilla-Montero, Benjamín Guadarrama-Benítez, Marco A. Aragón-Castro, Omar Morales-Ordaz, Rubén Gutiérrez-Rosales, Claudia Carrillo-Ponce, Marcela Janka-Zires, Luis Gabriel Vázquez-Lavista
-
Keith Chiu, Abdul Razack, Anthony Maraveyas
-
Julien Celestine, Arnaud Tanti, Arnaud Aubert